Skip to main content
. 2004 Jan;48(1):183–191. doi: 10.1128/AAC.48.1.183-191.2004

FIG. 2.

FIG. 2.

Plots of emtricitabine AUC0-∞ versus dose period (Treatment) in all subjects. ⋄, cohorts 2 and 3, 22 months to 5 years; ▵, cohort 4, 6 to 12 years; •, cohort 5, 13 to 17 years. The linear regression line is for dose periods 1 and 2.